Susquehanna Fundamental Investments’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-15,232
Closed -$53K 1831
2021
Q1
$53K Sell
15,232
-32,738
-68% -$114K ﹤0.01% 1495
2020
Q4
$161K Sell
47,970
-10,732
-18% -$36K ﹤0.01% 1386
2020
Q3
$206K Buy
+58,702
New +$206K 0.01% 1187